Evidence map›Paper›PMID 36227532›Full record

ArticleJournal of community genetics2022

Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.

Sarah M Lima, Meaghan Nazareth, Karen M Schmitt, Andria Reyes, Elaine Fleck, Gary K Schwartz, Mary Beth Terry, Grace C Hillyer

Open access · greenAbstract read
In one paragraph

Article in Journal of community genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sarah M LimaMailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA.
Meaghan NazarethMailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA.
Karen M SchmittHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Andria ReyesHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Elaine FleckDivision of Community and Population Health, New York Presbyterian Hospital, New York, NY, USA.
Gary K SchwartzHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Mary Beth TerryMailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA.
Grace C HillyerMailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA. gah28@cumc.columbia.edu.ORCID http://orcid.org/0000-0003-0467-075X
Columbia University Irving Medical Center · USColumbia University · USNewYork–Presbyterian Hospital · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
NCI NIH HHS P30CA013696
6 · The paper itself

Abstract

Risk-based genetic tests are often used to determine cancer risk, when to initiate screening, and frequency of screening, but rely on interest in genetic testing. We examined overall interest in genetic testing for cancer risk assessment and willingness to change behavior, and whether these are affected by demographic or socioeconomic factors.We conducted a community needs health survey in 2019 among primary care and cancer patients, family members and community members in New York City. We used univariable analysis and relative risk regression to examine interest in genetic cancer risk testing and willingness to modify lifestyle behaviors in response to an informative genetic test.Of the 1225 participants, 74.0% (n = 906) expressed interest in having a genetic test to assess cancer risk. Interest in genetic testing was high across all demographic and socioeconomic groups; reported interest in genetic testing by group ranged from 65.0 (participants aged 65 years and older) to 83.6% (participants below federal poverty level). Among the 906 participants that reported interest in genetic testing, 79.6% were willing to change eating habits, 66.5% to change exercise habits, and 49.5% to lose weight in response to an informative genetic test result.Our study reveals that interest in genetic testing for cancer risk is high among patients and community members and is high across demographic and socioeconomic groups, as is the reported willingness to change behavior. Based on these results, we recommend that population-based genetic testing may result in greater reduction cancer risk, particularly among minoritized groups.

Indexed as

Cancer riskCommunity healthGenetic testingLifestyle

Identifiers

PMID36227532
PMCPMC9681965
OpenAlexW4304893341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.